|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
22,000 |
|
|
Direct
Value |
$6,921,325 |
|
|
Indirect Value
|
$157,085 |
|
|
Total
Shares |
315,421 |
|
|
Total
Value |
$7,078,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
5
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
-23.9%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-05-24 |
63,339 |
2024-05-24 |
2,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-10-29 |
4 |
A |
$11.64 |
$3,421 |
D/D |
294 |
37,881 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-17 |
4 |
S |
$25.80 |
$12,900 |
D/D |
(500) |
61,256 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-17 |
4 |
OE |
$14.39 |
$7,195 |
D/D |
500 |
30,381 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-17 |
4 |
S |
$25.75 |
$206,000 |
D/D |
(8,000) |
29,881 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-18 |
4 |
OE |
$14.39 |
$451,486 |
D/D |
31,375 |
61,756 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-18 |
4 |
S |
$25.87 |
$811,546 |
D/D |
(31,375) |
29,881 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-04-29 |
4 |
A |
$11.64 |
$18,583 |
D/D |
1,597 |
31,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-03 |
4 |
OE |
$17.33 |
$178,690 |
D/D |
10,311 |
41,789 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-03 |
4 |
S |
$27.15 |
$279,895 |
D/D |
(10,311) |
31,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
43,978 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-25 |
4 |
OE |
$17.33 |
$159,037 |
D/D |
9,177 |
53,155 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-25 |
4 |
S |
$27.00 |
$247,779 |
D/D |
(9,177) |
43,978 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-26 |
4 |
OE |
$17.33 |
$702,073 |
D/D |
40,512 |
84,490 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-26 |
4 |
S |
$27.00 |
$1,093,828 |
D/D |
(40,512) |
43,978 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
46,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-10-28 |
4 |
AS |
$35.00 |
$590,625 |
D/D |
(16,875) |
46,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-10-28 |
4 |
OE |
$14.39 |
$242,831 |
D/D |
16,875 |
63,353 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-10-31 |
5 |
B |
$13.23 |
$2,658 |
D/D |
201 |
46,679 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-04-30 |
4 |
A |
$19.35 |
$19,462 |
D/D |
1,006 |
47,685 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
63,685 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-11 |
4 |
OE |
$14.39 |
$324,480 |
D/D |
21,530 |
68,340 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-11 |
4 |
S |
$37.07 |
$989,348 |
D/D |
(26,160) |
59,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
S |
$38.64 |
$386,373 |
D/D |
(10,000) |
59,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
OE |
$17.33 |
$173,300 |
D/D |
10,000 |
69,030 |
0 |
- |
|
170 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|